Syschem (India) Limited Reports No Deviation in Preferential Issue Fund Utilization for Q4 FY26
Syschem (India) Limited filed its Q4 FY26 compliance statement confirming no deviation in preferential issue fund utilization. The company raised Rs. 2021.25 lakhs on March 13, 2026, utilizing funds exclusively for working capital requirements as per original allocation. The Audit Committee reviewed and confirmed proper fund utilization according to shareholders' approval obtained in January 2025.

*this image is generated using AI for illustrative purposes only.
Syschem (India) Limited has submitted its quarterly compliance statement to BSE Limited, confirming no deviation or variation in the utilization of proceeds from its preferential issue for the quarter ended March 31, 2026. The statement was filed under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Fund Raising Details
The company completed its preferential issue on March 13, 2026, raising a total amount of Rs. 20,21,25,000. The fund raising was approved by shareholders on January 20, 2025, following the notice of shareholders meeting dated December 24, 2024.
Fund Utilization Breakdown
The preferential issue proceeds were allocated across four primary objectives with specific allocations:
| Objective | Original Allocation (Rs. in Lakhs) | Funds Utilized (Rs. in Lakhs) |
|---|---|---|
| Repayment of Security Deposit | 2435.00 | NIL |
| Capex Requirement | 500.00 | NIL |
| Working Capital Requirement | 5000.00 | 2021.25 |
| General Corporate Purpose | 248.00 | NIL |
| Total | 8183.00 | 2021.25 |
During the quarter ended March 31, 2026, the company utilized Rs. 2021.25 lakhs exclusively for meeting working capital requirements, which aligns with the original allocation plan.
Audit Committee Review
The Audit Committee conducted a comprehensive review of the funds utilization report presented by the Board. Following their assessment, the committee concluded that the funds were utilized for the purposes for which they were raised, as prescribed in the Notice of Shareholders Meeting dated December 24, 2024.
Compliance Confirmation
The company confirmed that there was no deviation or variation in the use of proceeds during the reporting quarter. All fund utilization remained within the approved framework, with no modifications to the original objects or allocations. The statement was duly signed by Company Secretary and Compliance Officer Shikha Kataria and Chief Financial Officer Sanjeev Agrawal, ensuring proper corporate governance compliance.
The filing demonstrates Syschem's adherence to regulatory requirements and transparent reporting of fund utilization to stakeholders and regulatory authorities.
Historical Stock Returns for Syschem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.57% | -3.25% | +15.83% | -6.98% | +22.93% | +584.74% |
What are Syschem's plans for utilizing the remaining Rs. 6,161.75 lakhs from the preferential issue in upcoming quarters?
How might the delay in capex investments and security deposit repayments impact Syschem's operational expansion timeline?
Will Syschem need to raise additional funds if working capital requirements exceed the allocated Rs. 5,000 lakhs?


































